Sodium-glucose cotransporter 2 inhibitors improved time-in-range without increasing hypoglycemia in Japanese patients with type 1 diabetes: A retrospective, single-center, pilot study.

Daisuke SuzukiHodaka YamadaMasashi YoshidaShunsuke FunazakiMisato AmamotoJun MorimotoKazuo Hara

Published in: Journal of diabetes investigation (2020)

SGLT2 inhibitors improved TIR and the mean glucose level and standard deviation without increasing the time below range <70 mg/dL in patients with type 1 diabetes.

Keyphrases

type diabetes
blood glucose
glycemic control
metabolic syndrome
insulin resistance